Zydus Lifesciences announced that the USFDA conducted an inspection at the group's Unit ' 2 manufacturing plant at Ankleshwar, Gujarat. The inspection was conducted from 19th to 23rd January, 2026 and concluded with 3 observations. There were no data integrity related observations. The Company will closely work with the USFDA to address the observations expeditiously.

Powered by Capital Market - Live News